| Dr Shyamsunder R Chakilum, MD | |
|
1409 E 84th Pl, Regional Mental Health Center, Merrillville, IN 46410-6451 | |
| (219) 794-2000 | |
| (219) 794-2010 |
| Full Name | Dr Shyamsunder R Chakilum |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 42 Years |
| Location | 1409 E 84th Pl, Merrillville, Indiana |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295706521 | NPI | - | NPPES |
| 000000700958 | Other | IN | ANTHEM BC/BS |
| 201011930 | Medicaid | IN |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bhc Streamwood Hospital Inc | 1759291461 | 13 |
News Archive
Mice engineered with a human gene for schizophrenia and exposed to lead during early life exhibited behaviors and structural changes in their brains consistent with schizophrenia.
There are three times as many people with the chronic and debilitating bowel disorder called inflammatory bowel disease (IBD) as ever thought before, according to a new study presented today at UEG Week 2019, at Barcelona. Not only is the condition a distressing one in itself, but patients with IBD have a higher risk of colorectal cancer as well.
Individuals with a high resting heart rate and a low beat-to-beat heart rate variability have an increased risk of developing kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The findings suggest that the behavior of the autonomic nervous system may be a sentinel marker for late development of certain cases of kidney disease.
Northwest Biotherapeutics, a biotechnology company developing DCVax-L personalized immune therapies for solid tumor cancers, today announced that its Phase III clinical trial with DCVax-L for brain cancer has been initiated at King's College Hospital in the UK.
› Verified 6 days ago
| Entity Name | Edward Health Ventures |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962452912 PECOS PAC ID: 4284531484 Enrollment ID: O20031216000616 |
News Archive
Mice engineered with a human gene for schizophrenia and exposed to lead during early life exhibited behaviors and structural changes in their brains consistent with schizophrenia.
There are three times as many people with the chronic and debilitating bowel disorder called inflammatory bowel disease (IBD) as ever thought before, according to a new study presented today at UEG Week 2019, at Barcelona. Not only is the condition a distressing one in itself, but patients with IBD have a higher risk of colorectal cancer as well.
Individuals with a high resting heart rate and a low beat-to-beat heart rate variability have an increased risk of developing kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The findings suggest that the behavior of the autonomic nervous system may be a sentinel marker for late development of certain cases of kidney disease.
Northwest Biotherapeutics, a biotechnology company developing DCVax-L personalized immune therapies for solid tumor cancers, today announced that its Phase III clinical trial with DCVax-L for brain cancer has been initiated at King's College Hospital in the UK.
› Verified 6 days ago
| Entity Name | Bhc Streamwood Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619916822 PECOS PAC ID: 1759291461 Enrollment ID: O20140324001101 |
News Archive
Mice engineered with a human gene for schizophrenia and exposed to lead during early life exhibited behaviors and structural changes in their brains consistent with schizophrenia.
There are three times as many people with the chronic and debilitating bowel disorder called inflammatory bowel disease (IBD) as ever thought before, according to a new study presented today at UEG Week 2019, at Barcelona. Not only is the condition a distressing one in itself, but patients with IBD have a higher risk of colorectal cancer as well.
Individuals with a high resting heart rate and a low beat-to-beat heart rate variability have an increased risk of developing kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The findings suggest that the behavior of the autonomic nervous system may be a sentinel marker for late development of certain cases of kidney disease.
Northwest Biotherapeutics, a biotechnology company developing DCVax-L personalized immune therapies for solid tumor cancers, today announced that its Phase III clinical trial with DCVax-L for brain cancer has been initiated at King's College Hospital in the UK.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shyamsunder R Chakilum, MD 8400 Louisiana St, C/o Geminus Corporation, Merrillville, IN 46410-6385 Ph: (219) 757-1928 | Dr Shyamsunder R Chakilum, MD 1409 E 84th Pl, Regional Mental Health Center, Merrillville, IN 46410-6451 Ph: (219) 794-2000 |
News Archive
Mice engineered with a human gene for schizophrenia and exposed to lead during early life exhibited behaviors and structural changes in their brains consistent with schizophrenia.
There are three times as many people with the chronic and debilitating bowel disorder called inflammatory bowel disease (IBD) as ever thought before, according to a new study presented today at UEG Week 2019, at Barcelona. Not only is the condition a distressing one in itself, but patients with IBD have a higher risk of colorectal cancer as well.
Individuals with a high resting heart rate and a low beat-to-beat heart rate variability have an increased risk of developing kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The findings suggest that the behavior of the autonomic nervous system may be a sentinel marker for late development of certain cases of kidney disease.
Northwest Biotherapeutics, a biotechnology company developing DCVax-L personalized immune therapies for solid tumor cancers, today announced that its Phase III clinical trial with DCVax-L for brain cancer has been initiated at King's College Hospital in the UK.
› Verified 6 days ago
Emilio Soria, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7891 Broadway Ste G, Merrillville, IN 46410 Phone: 219-756-8000 Fax: 219-756-3699 | |
Larry M Salberg, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 521 E 86th Ave, Suite Z, Merrillville, IN 46410 Phone: 219-769-0777 Fax: 219-755-0612 | |
Mohammad Javed, M.D Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 8555 Taft St, Merrillville, IN 46410 Phone: 219-769-4005 Fax: 219-769-2508 | |
Dana R Marlowe, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 8555 Taft St, Merrillville, IN 46410 Phone: 219-769-4005 Fax: 219-769-2508 | |
Jose Lorenzo Ramirez, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8555 Taft St, Merrillville, IN 46410 Phone: 219-769-4005 Fax: 219-769-2508 | |
Peter Gallagher, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 8555 Taft St, Merrillville, IN 46410 Phone: 219-769-4005 Fax: 219-769-2508 | |
Dr. Qun Wu, MD, MB Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8555 Taft St, Merrillville, IN 46410 Phone: 773-490-1544 Fax: 219-769-2508 |